- Home
- EFSC vs PTGX Comparison
EFSC vs PTGX Comparison
Compare EFSC & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFSC | PTGX |
|---|---|---|
| Founded | 1988 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 5.4B |
| IPO Year | 1999 | 2016 |
Fundamental Metrics
Financial Performance| Metric | EFSC | PTGX |
|---|---|---|
| Price | $56.78 | $95.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $65.67 | ★ $88.33 |
| AVG Volume (30 Days) | 147.3K | ★ 953.6K |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | ★ 8.68 | N/A |
| EPS | ★ 5.13 | 0.72 |
| Revenue | ★ $646,694,000.00 | $209,217,000.00 |
| Revenue This Year | $20.14 | N/A |
| Revenue Next Year | $5.15 | $296.47 |
| P/E Ratio | ★ $11.06 | $132.39 |
| Revenue Growth | ★ 9.31 | N/A |
| 52 Week Low | $45.22 | $33.70 |
| 52 Week High | $62.60 | $95.39 |
Technical Indicators
Market Signals| Indicator | EFSC | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 71.35 |
| Support Level | $56.13 | $88.30 |
| Resistance Level | $58.25 | $92.80 |
| Average True Range (ATR) | 1.29 | 2.80 |
| MACD | 0.27 | 0.28 |
| Stochastic Oscillator | 62.27 | 85.98 |
Price Performance
Historical ComparisonAbout EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.